Breaking News, Financial News

IQVIA 3Q Results

Research & Development Solutions revenue up 7% to $2.1 billion.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

IQVIA 3Q Revenues: $3.7 billion (+5%) 3QEarnings: $303 million (+7%) YTD Revenues: $11.1 billion (+4%) YTD Earnings: $889 million (+3%) Comments: Technology & Analytics Solutions (TAS) revenue was $1.4 billion, up 2% in the quarter. Research & Development Solutions (R&DS) revenue was $2.1 billion, up 7%. Contract Sales & Medical Solutions (CSMS) revenue was flat at $183 million.   At the end of the quarter, R&DS contracted backlog, including reimbursed expenses, was $2...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters